Middle-East and Africa Hypertension Drugs Market information, by Type (Thiazide diuretics, Beta blockers, Angiotensin-converting enzyme (ACE) inhibitors, Angiotensin II receptor blockers, Calcium channel blockers, Renin inhibitors, Alpha blockers, Alpha-beta blockers, Central-acting agents, Vasodilators, Aldosterone antagonists) - Forecast to 2032

Middle-East and Africa Hypertension Drugs Market Overview

Hypertension Drugs Market Size was valued at USD 439.67 Billion in 2023. The Global Hypertension Drugs industry is projected to grow from USD 472.58 Billion in 2024 to USD 780.96 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.74% during the forecast period (2024 - 2032).

Study objectives of Middle-East and Africa Hypertension Drugs Market:

• To provide detailed analysis of the market structure along with forecast for the next 5 years of the various segments and sub-segments of the Middle-East and Africa Hypertension Drugs Market


• To provide insights about factors affecting the market growth


• To analyze the Middle-East and Africa Hypertension Drugs Market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.


• To provide historical and forecast revenue of the market segments and sub-segments with respect to two main geographies and their countries- Middle East & Africa.


• To provide country level analysis of the market with respect to the current market size and future prospective


• To provide country level analysis of the market for segments by type and its sub-segments.


• To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market


• To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Middle-East and Africa Hypertension Drugs Market.

Middle-East and Africa Hypertension Drugs Market by Type 

Intended Audience

• Middle-East and Africa Hypertension Drugs manufacturers


• Middle-East and Africa Hypertension Drugs Suppliers


• Government and Independent Regulatory Authorities


• Research and Development (R&D) Companies


• Independent Research Laboratories


• Market Research and Consulting Service Providers


• Medical Research Laboratories

Market Synopsis of Middle-East and Africa Hypertension Drugs Market:

Market Scenario:

The Middle-East and Africa Hypertension Drugs Market is projected to reach USD 6,985.6 Million by 2030 at 6.1% CAGR during the forecast period 2022-2030. Hypertension or high blood pressure is the condition when blood pressure increases to the unhealthy level. Hypertension is very harmful and it can lead to stroke, heart failure, heart attack and kidney diseases. The main purpose of anti-hypertension drug is to lower and control high blood pressure to protect organs like brain, heart, kidneys. Hypertension affects four out of ten adults in Middle East and Africa region. Over 1.5 million deaths occurs due to hypertension in Middle East and Africa. Countries in Middle East and Africa bear a heavy burden from hypertension diagnosis and treatment. Huge funding in R&D and various initiatives by government are driving the growth for Hypertension Drugs Market in Middle East and Africa.

Middle-East and Africa Hypertension Drugs Market Segments

Middle-East and Africa Hypertension Drugs Market has been segmented on the basis of type which comprise Thiazide diuretics, Beta blockers, Angiotensin-converting enzyme (ACE) inhibitors, Angiotensin II receptor blockers, Calcium channel blockers, Renin inhibitors, Alpha blockers, Alpha-beta blockers, Central-acting agents, Vasodilators, Aldosterone antagonists, and others.

Regional Analysis of Middle-East and Africa Hypertension Drugs Market:    

Considering the Middle-East and Africa Hypertension Drugs Market scenario, UAE region is believed to be the largest market for Middle-East and Africa Hypertension Drugs. Moreover Saudi Arabia market is also growing and second largest market for Hypertension Drugs. On the other hand, Egypt market is expected to grow at the steady pace in the Middle-East and Africa Hypertension Drugs during the forecasted period. Rest of the Middle East and Africa region is likely to have a limited but steady growth in the market.

Key Players for Middle-East and Africa Hypertension Drugs Market:   

• Abbott (US)


• Johnson & Johnson Services, Inc. (US)


• Novartis (Switzerland)


• GlaxoSmithKline plc.(UK)


• AstraZeneca (UK)


• Bayer AG (Germany)


• Pfizer Inc.(US)


• Merck & Co., Inc. (US)


• Sanofi (France)


• F. Hoffmann-La Roche Ltd (Switzerland)


• Gilead (US)

The report for Middle-East and Africa Hypertension Drugs Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions